Floatz logo

Metformin

Obstructive Sleep Apnoea

Pennington Biomedical Research CenterSmall moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Obstructive Sleep Apnoea cohort.

Asset / SponsorPhaseRating
Liraglutide
St Vincent's University Hospital, Ireland
Phase 3BB
nnc0487-0111
Novo Nordisk A/S
Phase 3B

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →